Wells Fargo & Company Repare Therapeutics Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPTX
# of Institutions
69Shares Held
36.6MCall Options Held
51.7KPut Options Held
17.7K-
Bvf Inc San Francisco, CA10.3MShares$37 Million1.04% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$12.1 Million4.62% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$11.9 Million0.26% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$10.6 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$9.48 Million19.39% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $150M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...